0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Autogenous Vaccines Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-22Z1818
Home | Market Reports | Health | Health Conditions | Infectious Diseases
China Autogenous Vaccines Market Report Forecast 2021 2027

China Autogenous Vaccines Market Report & Forecast 2021-2027

Code: QYRE-Auto-22Z1818
Report
October 2021
109 Pages
QYResearch
Region: Global, North America, Japan, China, Europe, France, Germany, Italy, Philippines, Malaysia, Thailand, Taiwan, Saudi Arabia, Turkey, South Korea, India, Australia, Indonesia,
Description
Table of Content
Tables & Figures
China Autogenous Vaccines Market, By Obejection, 2016-2021, 2022-2027 ($ Millions) & (M Does)
China Autogenous Vaccines Market Segment Percentages, By Obejection, 2020 (%)
Poultry
Fishes
Pigs & Cattle
Other
China Autogenous Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Does)
China Autogenous Vaccines Market Segment Percentages, By Application, 2020 (%)
Large Farms
Small Farms
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autogenous Vaccines revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Autogenous Vaccines revenues share in China market, 2020 (%)
Key companies Autogenous Vaccines sales in China market, 2016-2021 (Estimated), (M Does)
Key companies Autogenous Vaccines sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Boehringer Ingelheim
Vaxxinova
Zoetis
Ceva Biovac
Phibro
Elanco
AniCon Labor GmbH
Cambridge Technologies
AVICARE plus
Genova Labs
Addison Biological Laboratory
ACE Laboratory Services
Deltamune
Dyntec
Hygieia Biological Laboratories
1 Introduction to Research & Analysis Reports
1.1 Autogenous Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Obejection
1.2.2 Segment by Application
1.3 China Autogenous Vaccines Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Autogenous Vaccines Overall Market Size
2.1 China Autogenous Vaccines Market Size: 2021 VS 2027
2.2 China Autogenous Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 China Autogenous Vaccines Sales: 2016-2027
3 Company Landscape
3.1 Top Autogenous Vaccines Players in China Market
3.2 Top China Autogenous Vaccines Companies Ranked by Revenue
3.3 China Autogenous Vaccines Revenue by Companies
3.4 China Autogenous Vaccines Sales by Companies
3.5 China Autogenous Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Autogenous Vaccines Companies in China Market, by Revenue in 2020
3.7 Manufacturers Autogenous Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Autogenous Vaccines Players in China Market
3.8.1 List of Tier 1 Autogenous Vaccines Companies in China
3.8.2 List of Tier 2 and Tier 3 Autogenous Vaccines Companies in China
4 Sights by Obejection
4.1 Overview
4.1.1 By Obejection - China Autogenous Vaccines Market Size Markets, 2021 & 2027
4.1.2 Poultry
4.1.3 Fishes
4.1.4 Pigs & Cattle
4.1.5 Other
4.2 By Obejection - China Autogenous Vaccines Revenue & Forecasts
4.2.1 By Obejection - China Autogenous Vaccines Revenue, 2016-2021
4.2.2 By Obejection - China Autogenous Vaccines Revenue, 2022-2027
4.2.3 By Obejection - China Autogenous Vaccines Revenue Market Share, 2016-2027
4.3 By Obejection - China Autogenous Vaccines Sales & Forecasts
4.3.1 By Obejection - China Autogenous Vaccines Sales, 2016-2021
4.3.2 By Obejection - China Autogenous Vaccines Sales, 2022-2027
4.3.3 By Obejection - China Autogenous Vaccines Sales Market Share, 2016-2027
4.4 By Obejection - China Autogenous Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Autogenous Vaccines Market Size, 2021 & 2027
5.1.2 Large Farms
5.1.3 Small Farms
5.2 By Application - China Autogenous Vaccines Revenue & Forecasts
5.2.1 By Application - China Autogenous Vaccines Revenue, 2016-2021
5.2.2 By Application - China Autogenous Vaccines Revenue, 2022-2027
5.2.3 By Application - China Autogenous Vaccines Revenue Market Share, 2016-2027
5.3 By Application - China Autogenous Vaccines Sales & Forecasts
5.3.1 By Application - China Autogenous Vaccines Sales, 2016-2021
5.3.2 By Application - China Autogenous Vaccines Sales, 2022-2027
5.3.3 By Application - China Autogenous Vaccines Sales Market Share, 2016-2027
5.4 By Application - China Autogenous Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Overview
6.1.3 Boehringer Ingelheim Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.1.4 Boehringer Ingelheim Autogenous Vaccines Product Description
6.1.5 Boehringer Ingelheim Recent Developments
6.2 Vaxxinova
6.2.1 Vaxxinova Corporation Information
6.2.2 Vaxxinova Overview
6.2.3 Vaxxinova Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.2.4 Vaxxinova Autogenous Vaccines Product Description
6.2.5 Vaxxinova Recent Developments
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Overview
6.3.3 Zoetis Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.3.4 Zoetis Autogenous Vaccines Product Description
6.3.5 Zoetis Recent Developments
6.4 Ceva Biovac
6.4.1 Ceva Biovac Corporation Information
6.4.2 Ceva Biovac Overview
6.4.3 Ceva Biovac Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.4.4 Ceva Biovac Autogenous Vaccines Product Description
6.4.5 Ceva Biovac Recent Developments
6.5 Phibro
6.5.1 Phibro Corporation Information
6.5.2 Phibro Overview
6.5.3 Phibro Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.5.4 Phibro Autogenous Vaccines Product Description
6.5.5 Phibro Recent Developments
6.6 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Overview
6.6.3 Elanco Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.6.4 Elanco Autogenous Vaccines Product Description
6.6.5 Elanco Recent Developments
6.7 AniCon Labor GmbH
6.7.1 AniCon Labor GmbH Corporation Information
6.7.2 AniCon Labor GmbH Overview
6.7.3 AniCon Labor GmbH Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.7.4 AniCon Labor GmbH Autogenous Vaccines Product Description
6.7.5 AniCon Labor GmbH Recent Developments
6.8 Cambridge Technologies
6.8.1 Cambridge Technologies Corporation Information
6.8.2 Cambridge Technologies Overview
6.8.3 Cambridge Technologies Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.8.4 Cambridge Technologies Autogenous Vaccines Product Description
6.8.5 Cambridge Technologies Recent Developments
6.9 AVICARE plus
6.9.1 AVICARE plus Corporation Information
6.9.2 AVICARE plus Overview
6.9.3 AVICARE plus Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.9.4 AVICARE plus Autogenous Vaccines Product Description
6.9.5 AVICARE plus Recent Developments
6.10 Genova Labs
6.10.1 Genova Labs Corporation Information
6.10.2 Genova Labs Overview
6.10.3 Genova Labs Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.10.4 Genova Labs Autogenous Vaccines Product Description
6.10.5 Genova Labs Recent Developments
6.11 Addison Biological Laboratory
6.11.1 Addison Biological Laboratory Corporation Information
6.11.2 Addison Biological Laboratory Overview
6.11.3 Addison Biological Laboratory Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.11.4 Addison Biological Laboratory Autogenous Vaccines Product Description
6.11.5 Addison Biological Laboratory Recent Developments
6.12 ACE Laboratory Services
6.12.1 ACE Laboratory Services Corporation Information
6.12.2 ACE Laboratory Services Overview
6.12.3 ACE Laboratory Services Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.12.4 ACE Laboratory Services Autogenous Vaccines Product Description
6.12.5 ACE Laboratory Services Recent Developments
6.13 Deltamune
6.13.1 Deltamune Corporation Information
6.13.2 Deltamune Overview
6.13.3 Deltamune Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.13.4 Deltamune Autogenous Vaccines Product Description
6.13.5 Deltamune Recent Developments
6.14 Dyntec
6.14.1 Dyntec Corporation Information
6.14.2 Dyntec Overview
6.14.3 Dyntec Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.14.4 Dyntec Autogenous Vaccines Product Description
6.14.5 Dyntec Recent Developments
6.15 Hygieia Biological Laboratories
6.15.1 Hygieia Biological Laboratories Corporation Information
6.15.2 Hygieia Biological Laboratories Overview
6.15.3 Hygieia Biological Laboratories Autogenous Vaccines Sales and Revenue in China Market (2016-2021)
6.15.4 Hygieia Biological Laboratories Autogenous Vaccines Product Description
6.15.5 Hygieia Biological Laboratories Recent Developments
7 China Autogenous Vaccines Production Capacity, Analysis
7.1 China Autogenous Vaccines Production Capacity, 2016-2027
7.2 Autogenous Vaccines Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Autogenous Vaccines Supply Chain Analysis
9.1 Autogenous Vaccines Industry Value Chain
9.2 Autogenous Vaccines Upstream Market
9.3 Autogenous Vaccines Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Autogenous Vaccines Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
    Table 1. Key Players of Autogenous Vaccines in China Market
    Table 2. Top Autogenous Vaccines Players in China Market, Ranking by Revenue (2019)
    Table 3. China Autogenous Vaccines Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. China Autogenous Vaccines Revenue Share by Companies, 2016-2021
    Table 5. China Autogenous Vaccines Sales by Companies, (M Does), 2016-2021
    Table 6. China Autogenous Vaccines Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Autogenous Vaccines Price (2016-2021) & (US$/Does)
    Table 8. Manufacturers Autogenous Vaccines Product Type
    Table 9. List of Tier 1 Autogenous Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Autogenous Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. Major Manufacturers of Poultry
    Table 12. Major Manufacturers of Fishes
    Table 13. By Obejection – China Autogenous Vaccines Revenue, (US$, Mn), 2021 & 2027
    Table 14. By Obejection - China Autogenous Vaccines Revenue (US$, Mn), 2016-2021
    Table 15. By Obejection - China Autogenous Vaccines Revenue (US$, Mn), 2022-2027
    Table 16. By Obejection - China Autogenous Vaccines Sales (M Does), 2016-2021
    Table 17. By Obejection - China Autogenous Vaccines Sales (M Does), 2022-2027
    Table 18. By Application – China Autogenous Vaccines Revenue, (US$, Mn), 2021 VS 2027
    Table 19. By Application - China Autogenous Vaccines Revenue (US$, Mn), 2016-2021
    Table 20. By Application - China Autogenous Vaccines Revenue (US$, Mn), 2022-2027
    Table 21. By Application - China Autogenous Vaccines Sales (M Does), 2016-2021
    Table 22. By Application - China Autogenous Vaccines Sales (M Does), 2022-2027
    Table 23. Boehringer Ingelheim Corporation Information
    Table 24. Boehringer Ingelheim Description and Major Businesses
    Table 25. Boehringer Ingelheim Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 26. Boehringer Ingelheim Autogenous Vaccines Product
    Table 27. Boehringer Ingelheim Recent Developments
    Table 28. Vaxxinova Corporation Information
    Table 29. Vaxxinova Description and Major Businesses
    Table 30. Vaxxinova Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 31. Vaxxinova Autogenous Vaccines Product
    Table 32. Vaxxinova Recent Developments
    Table 33. Zoetis Corporation Information
    Table 34. Zoetis Description and Major Businesses
    Table 35. Zoetis Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 36. Zoetis Autogenous Vaccines Product
    Table 37. Zoetis Recent Developments
    Table 38. Ceva Biovac Corporation Information
    Table 39. Ceva Biovac Description and Major Businesses
    Table 40. Ceva Biovac Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 41. Ceva Biovac Autogenous Vaccines Product
    Table 42. Ceva Biovac Recent Developments
    Table 43. Phibro Corporation Information
    Table 44. Phibro Description and Major Businesses
    Table 45. Phibro Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 46. Phibro Autogenous Vaccines Product
    Table 47. Phibro Recent Developments
    Table 48. Elanco Corporation Information
    Table 49. Elanco Description and Major Businesses
    Table 50. Elanco Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 51. Elanco Autogenous Vaccines Product
    Table 52. Elanco Recent Developments
    Table 53. AniCon Labor GmbH Corporation Information
    Table 54. AniCon Labor GmbH Description and Major Businesses
    Table 55. AniCon Labor GmbH Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 56. AniCon Labor GmbH Autogenous Vaccines Product
    Table 57. AniCon Labor GmbH Recent Developments
    Table 58. Cambridge Technologies Corporation Information
    Table 59. Cambridge Technologies Description and Major Businesses
    Table 60. Cambridge Technologies Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 61. Cambridge Technologies Autogenous Vaccines Product
    Table 62. Cambridge Technologies Recent Developments
    Table 63. AVICARE plus Corporation Information
    Table 64. AVICARE plus Description and Major Businesses
    Table 65. AVICARE plus Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 66. AVICARE plus Autogenous Vaccines Product
    Table 67. AVICARE plus Recent Developments
    Table 68. Genova Labs Corporation Information
    Table 69. Genova Labs Description and Major Businesses
    Table 70. Genova Labs Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 71. Genova Labs Autogenous Vaccines Product
    Table 72. Genova Labs Recent Developments
    Table 73. Addison Biological Laboratory Corporation Information
    Table 74. Addison Biological Laboratory Description and Major Businesses
    Table 75. Addison Biological Laboratory Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 76. Addison Biological Laboratory Autogenous Vaccines Product
    Table 77. Addison Biological Laboratory Recent Developments
    Table 78. ACE Laboratory Services Corporation Information
    Table 79. ACE Laboratory Services Description and Major Businesses
    Table 80. ACE Laboratory Services Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 81. ACE Laboratory Services Autogenous Vaccines Product
    Table 82. ACE Laboratory Services Recent Developments
    Table 83. Deltamune Corporation Information
    Table 84. Deltamune Description and Major Businesses
    Table 85. Deltamune Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 86. Deltamune Autogenous Vaccines Product
    Table 87. Deltamune Recent Developments
    Table 88. Dyntec Corporation Information
    Table 89. Dyntec Description and Major Businesses
    Table 90. Dyntec Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 91. Dyntec Autogenous Vaccines Product
    Table 92. Dyntec Recent Developments
    Table 93. Hygieia Biological Laboratories Corporation Information
    Table 94. Hygieia Biological Laboratories Description and Major Businesses
    Table 95. Hygieia Biological Laboratories Autogenous Vaccines Sales (M Does), Revenue (US$, Mn) and Gross Margin (US$/Does) (2016-2021)
    Table 96. Hygieia Biological Laboratories Autogenous Vaccines Product
    Table 97. Hygieia Biological Laboratories Recent Developments
    Table 98. Autogenous Vaccines Production Capacity (M Does) of Key Manufacturers in China Market, 2019-2021 (M Does)
    Table 99. China Autogenous Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
    Table 100. Autogenous Vaccines Market Opportunities & Trends in China Market
    Table 101. Autogenous Vaccines Market Drivers in China Market
    Table 102. Autogenous Vaccines Market Restraints in China Market
    Table 103. Autogenous Vaccines Raw Materials
    Table 104. Autogenous Vaccines Raw Materials Suppliers in China Market
    Table 105. Typical Autogenous Vaccines Downstream
    Table 106. Autogenous Vaccines Downstream Clients in China Market
    Table 107. Autogenous Vaccines Distributors and Sales Agents in China Market
List of Figures
    Figure 1. Autogenous Vaccines Product Picture
    Figure 2. Autogenous Vaccines Segment by Obejection
    Figure 3. Autogenous Vaccines Segment by Application
    Figure 4. China Autogenous Vaccines Market Overview: 2020
    Figure 5. China Autogenous Vaccines Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. China Autogenous Vaccines Revenue, 2016-2027 (US$, Mn)
    Figure 7. Autogenous Vaccines Sales in China Market: 2016-2027 (M Does)
    Figure 8. The Top 3 and 5 Players Market Share by Autogenous Vaccines Revenue in 2020
    Figure 9. Poultry Product Picture
    Figure 10. Fishes Product Picture
    Figure 11. Pigs & Cattle Product Picture
    Figure 12. Other Product Picture
    Figure 13. By Obejection - China Autogenous Vaccines Sales Market Share, 2016-2027
    Figure 14. By Obejection - China Autogenous Vaccines Revenue Market Share, 2016-2027
    Figure 15. By Obejection - China Autogenous Vaccines Price (US$/Does), 2016-2027
    Figure 16. Large Farms
    Figure 17. Small Farms
    Figure 18. By Application - China Autogenous Vaccines Sales Market Share, 2016-2027
    Figure 19. By Application - China Autogenous Vaccines Revenue Market Share, 2016-2027
    Figure 20. By Application - China Autogenous Vaccines Price (US$/Does), 2016-2027
    Figure 21. Boehringer Ingelheim Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 22. Vaxxinova Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 23. Zoetis Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 24. Ceva Biovac Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 25. Phibro Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 26. Elanco Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 27. AniCon Labor GmbH Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 28. Cambridge Technologies Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 29. AVICARE plus Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 30. Genova Labs Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 31. Addison Biological Laboratory Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 32. ACE Laboratory Services Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 33. Deltamune Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 34. Dyntec Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 35. Hygieia Biological Laboratories Autogenous Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 36. China Autogenous Vaccines Production Capacity (M Does), 2016-2027
    Figure 37. Autogenous Vaccines Industry Value Chain
    Figure 38. Marketing Channels
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global and China Mycobacterium Tuberculosis Antibodies Market Insights Forecast to 2027
Global and China Mycobacterium Tuberculosis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-15D7777
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Escherichia Coli Antibody Market Insights Forecast to 2027
Global and China Escherichia Coli Antibody Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20G7629
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States Chlamydia Trachomatis Antibodies Market Insights Forecast to 2027
Global and United States Chlamydia Trachomatis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-21F7760
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Prophylactic HIV Drug Market Insights Forecast to 2027
Global and China Prophylactic HIV Drug Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7T7637
Sun Nov 21 00:00:00 UTC 2021

Add to Cart